Ambry Genetics Announces GenomeNext™, a Whole Genome Sequencing Test Solution to Improve Diagnosis for Rare Diseases

Go back to Ambry Genetics Announces GenomeNext™, a Whole Genome Sequencing Test Solution to Improve Diagnosis for Rare Diseases
StemCells, Inc. (NASDAQ: TEM) Delayed: 62.17 -5.59 (8.25%)
Previous Close $67.76    52 Week High $0.45 
Open $66.10    52 Week Low $0.37 
Day High $68.29    P/E N/A 
Day Low $61.51    EPS $-0.31 
Volume 3,722,114